Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-08 |
mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-07 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-07 |
mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-07 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-07 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-07 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-07 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |